1. Chazov EI. Ho w to reduce mortality from cardiovascular diseases. Terapevticheskiy arkhiv = Therapeutic Archive. 2008;80(8):11–6 (In Russ.)
2. Oshchepkova EV, Efremova IuE, Karpov IuA. Myocardial infarction morbidity and mortality in the Russian Federation in 2000–2011. Terapevticheskiy arkhiv = Therapeutic Archive. 2013;85(4):4–10 (In Russ.)
3. Smirnova MD, Ageev FT. Statins — old myths and new facts. RMZh = RMJ. 2017;(20):1421–8 (In Russ.)
4. Sukhaterina NA. Dynamics of lipid spectrum and markers of infl ammation in the patients receiving atorvastatin in hypertensive patients combined with chronic obstructive pulmonary disease. Ateroskleroz i dislipidemii = Journal of Atheros clerosis and Dyslipidemias. 2016;(3):68– 74 (In Russ.)
5. Nedogoda SV. Rosuvastatin: evidence base and signifi cance for real clinical practice. RMZh = RMJ. 2015;(15):886 (In Russ.)